Tag Health & medicine
Waisman Center research into the molecular mysteries of Rett Syndrome may ultimately help an 8-year-old girl who suffers from the rare neurological disorder.
UW-Madison researchers, with the help of citizen scientists, tracked bird deaths along Lake Michigan, and found that warm waters and algae apparently promoted the growth of botulism toxin-producing bacteria that caused them.
Scientists and physicians needed a better model to understand neurofibromatosis in order to help affected children. A groundbreaking research partnership at UW–Madison is showing the way.
Promising results in the lab and in animal models could set the stage for developing a treatment for Alexander disease, a rare and usually fatal neurological disease with no known cure.
Participants in a study saw significant improvements on two measures of walking gait, and on balance, after 8 weeks of yoga classes.
UW-Madison professor of family medicine Paul Smith is leading the development and testing of Care Talks to help people improve communication with the medical system.
“The shelter was on top of this very quickly,” says clinical assistant professor Sandra Newbury, who has been leading the response.
The campus-based, face-to-face program will enroll a cohort of 32 second-degree students who will begin coursework in May 2018 for the twelve-month, full-time, year-round program.
A wet and warm summer — much like last year, when EEE virus infected 18 horses in 11 Wisconsin counties — makes for good mosquito habitat and conditions conducive to the spread of viruses like EEE and West Nile virus.
The role of bat parasites in maintaining chains of viral infection is little studied, and the new study serves up some intriguing insights into how viruses co-opt parasites to help do the dirty work of disease transmission.
A University of Wisconsin–Madison spinoff that makes an innovative material designed to speed healing of serious burns has begun a large clinical trial for the “regenerative skin tissue” it has been developing since 2000.
The Precision Medicine Molecular Tumor Board has a dual mission: consulting with oncologists statewide about targeted drugs to battle out-of-control cancers; and amassing data on what works and what does not.
A team led by Igor Slukvin, a University of Wisconsin–Madison professor, describes the developmental pathway that gives rise to the different types of cells that make up human vasculature.